# Effect of Re-esterified Triglyceride (rTG) Form Omega-3 Supplements on Dry Eye Following Cataract Surgery

> **NCT04411615** · NA · UNKNOWN · sponsor: **Samsung Medical Center** · enrollment: 30 (estimated)

## Conditions studied

- Dry Eye

## Interventions

- **DRUG:** Omega 3

## Key facts

- **NCT ID:** NCT04411615
- **Lead sponsor:** Samsung Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-07-01
- **Primary completion:** 2020-08-01
- **Final completion:** 2021-02-28
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2020-06-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04411615

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04411615, "Effect of Re-esterified Triglyceride (rTG) Form Omega-3 Supplements on Dry Eye Following Cataract Surgery". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04411615. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*